Ann Intern Med 1992, 117:292–301.Ĭamacho L, Soignet S, Chanel S, et al.: Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. This paper demonstrates the role of annexin II in the coagulopathy associated with acute promyelocytic leukemia and the effect of all-trans-retinoic acid (ATRA) on annexin II.įrankel SR, Eardley A, Lauwers G, et al.: The ‘retinoic acid syndrome’ in acute promyelocytic leukemia. Menell J, Cesarman G, Jacovina A, et al.: Annexin II and bleeding in acute promyelocytic leukemia. Clinical trials and side effects are reviewed. Update on the treatment of patients with acute promyelocytic leukemia. Lo Coco F, Nervi C, Avvisati G, Mandelli F: Acute promyelocytic leukemia: a curable disease. Blood 1996, 88:2826–2832.įrankel SR: Acute promyelocytic leukemia: new insights into diagnosis and therapy. Raelson JV, Nervi C, Rosenauer A, et al.: The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Haematologica 1999, 84:963–968.ĭegos L, Dombret H, Chomienne C, et al.: All-trans retinoic acid as a differentiation agent in the treatment of acute promyelocytic leukemia. Marasca R, Zucchini P, Galimberti S, et al.: Missense mutations in the PML/RAR alpha ligand binding domain in ATRAresistant As 2O 3 sensitive relapsed acute promyelocytic leukemia. Warrell RP Jr, Frankel SR, Miller WH Jr, et al.: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). In vitro studies: structure-function relationship. Cancer Chemother Pharmacol 1997, 40( suppl):S25-S29.Ĭhomienne C, Ballerini P, Balitrand N, et al.: All trans retinoic acid in promyelocytic leukemias. Soignet S, Fleischauer A, Polyak T, et al.: All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long term follow-up of the New York study. Blood 1988, 72:567–576.Ĭastaigne S, Chomienne C, Daniel MT, et al.: All-trans retinoic acid: a differentiation therapy for acute promyelocytic leukemia. Huang M, Yu Chen Y, Shu Rong C, et al.: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Br J Haematol 1998, 102:1035–1041.įenaux P, Pollet JP, Vanden Bossche L, et al.: Treatment of acute promyelocytic leukemia: a report of 70 cases. Guglielmi C, Martelli MP, Diverio D, et al.: Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome: a cooperative Italian study on 196 cases. Miller WH Jr, Levine K, DeBlasio A, et al.: Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. N Engl J Med 1993, 329:177–189.īiondi A, Rambaldi A, Pandolfi PP, et al.: Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute polymerase chain reaction. Warrell RP Jr, De The H, Wang Z, Degos L: Acute promyelocytic leukemia. Am J Hematol 1980, 8:347–359.ĭe The H, Lavau C, Marchio A, et al.: The PML RAR alpha fusion in RNA generated by the t(15 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Semin Oncol 1997, 24:92–102.ĭaly PA, Schiffer CA, Wiernik PH: Acute promyelocytic leukemia: clinical management of 15 patients. Leukemia 1994, 8:1264–1268.įenaux P, Chomienne C, Degos L: Acute promyelocytic leukemia: biology and treatment. Pediatr Hematol Oncol 1998, 15:203–206.īiondi A, Rovelli A, Cantu-Rajnoldi A, et al.: Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Schaison GS: Acute promyelocytic leukemia in children. Ebb D, Weinstein H: Diagnosis and treatment of childhood acute myelogenous leukemia.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |